Oncology

Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases

Conditions:   Malignant Neoplasm;   Metastatic Malignant Neoplasm in the Brain
Interventions:   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Radiation: Stereotactic Radiosurgery
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 18, 2018 / by / in
Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients

Condition:   Sedentary Lifestyle
Intervention:   Behavioral: eHealth for Sedentary Behavior
Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 17, 2018 / by / in
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

Conditions:   Malignant Solid Tumors;   Other Neoplasms Solid Tumors;   Pediatric Solid Tumor;   Refractory Solid Tumors;   Solid Tumor
Intervention:  
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 15, 2018 / by / in
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

Conditions:   Glioma;   Glioma of Brain;   Cancer;   Pediatric Cancer;   Pediatric Brain Tumor;   Astrocytoma;   Glioblastoma;   Hemispheric
Intervention:   Other: Specialized tumor board recommendation
Sponsors:   University of California, San Francisco;   Pacific Pediatric Neuro-Oncology Consortium
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 14, 2018 / by / in
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

Condition:   Ovarian Cancer Recurrent
Interventions:   Drug: Rintatolimod;   Drug: Pembrolizumab;   Drug: Cisplatin
Sponsors:   Robert Edwards;   Hemispherx Biopharma;   Merck Sharp & Dohme Corp.
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 13, 2018 / by / in
Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Conditions:   Locally Advanced Digestive System Neuroendocrine Carcinoma;   Locally Advanced Pancreatic Neuroendocrine Carcinoma;   Metastatic Digestive System Neuroendocrine Carcinoma;   Metastatic Pancreatic Neuroendocrine Carcinoma;   Refractory Digestive System Neuroendocrine Carcinoma;   Refractory Pancreatic Neuroendocrine Carcinoma;   Unresectable Digestive System Neuroendocrine Carcinoma;   Unresectable Pancreatic Neuroendocrine Carcinoma
Interventions:   Drug: Fluorouracil;   Drug: Leucovorin;   Drug: Liposomal Irinotecan;   Procedure: Quality-of-Life Assessment
Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 12, 2018 / by / in
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Conditions:   Stage II Fallopian Tube Cancer AJCC v8;   Stage II Ovarian Cancer AJCC v8;   Stage II Primary Peritoneal Cancer AJCC v8;   Stage IIA Fallopian Tube Cancer AJCC v8;   Stage IIA Ovarian Cancer AJCC v8;   Stage IIA Primary Peritoneal Cancer AJCC v8;   Stage IIB Fallopian Tube Cancer AJCC v8;   Stage IIB Ovarian Cancer AJCC v8;   Stage IIB Primary Peritoneal Cancer AJCC v8;   Stage III Fallopian Tube Cancer AJCC v8;   Stage III Ovarian Cancer AJCC v8;   Stage III Primary Peritoneal Cancer AJCC v8;   Stage IIIA Fallopian Tube Cancer AJCC v8;   Stage IIIA Ovarian Cancer AJCC v8;   Stage IIIA Primary Peritoneal Cancer AJCC v8;   Stage IIIA1 Fallopian Tube Cancer AJCC v8;   Stage IIIA1 Ovarian Cancer AJCC v8;   Stage IIIA2 Fallopian Tube Cancer AJCC v8;   Stage IIIA2 Ovarian Cancer AJCC v8;   Stage IIIB Fallopian Tube Cancer AJCC v8;   Stage IIIB Ovarian Cancer AJCC v8;   Stage IIIB Primary Peritoneal Cancer AJCC v8;   Stage IIIC Fallopian Tube Cancer AJCC v8;   Stage IIIC Ovarian Cancer AJCC v8;   Stage IIIC Primary Peritoneal Cancer AJCC v8;   Stage IV Fallopian Tube Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Primary Peritoneal Cancer AJCC v8;   Stage IVA Fallopian Tube Cancer AJCC v8;   Stage IVA Ovarian Cancer AJCC v8;   Stage IVA Primary Peritoneal Cancer AJCC v8;   Stage IVB Fallopian Tube Cancer AJCC v8;   Stage IVB Ovarian Cancer AJCC v8;   Stage IVB Primary Peritoneal Cancer AJCC v8
Interventions:   Biological: Alpha-type-1 Polarized Dendritic Cells;   Biological: Autologous Natural Killer Cell-like CTLs
Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 11, 2018 / by / in
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

Conditions:   Locally Advanced Lung Carcinoma;   Non-Small Cell Lung Carcinoma;   Small Cell Lung Carcinoma;   Stage III Lung Cancer AJCC v8;   Stage IIIA Lung Cancer AJCC v8;   Stage IIIB Lung Cancer AJCC v8;   Stage IIIC Lung Cancer AJCC v8
Interventions:   Drug: Phytochlorin Sodium-Polyvinylpyrrolidone Complex;   Procedure: Ultrasound-Guided Transbronchial Needle-Delivered Interstitial Photodynamic Therapy
Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

November 8, 2018 / by / in